1. Home
  2. NDLS vs GBIO Comparison

NDLS vs GBIO Comparison

Compare NDLS & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • GBIO
  • Stock Information
  • Founded
  • NDLS 1995
  • GBIO 2016
  • Country
  • NDLS United States
  • GBIO United States
  • Employees
  • NDLS N/A
  • GBIO N/A
  • Industry
  • NDLS Restaurants
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • NDLS Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • NDLS Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • NDLS 32.9M
  • GBIO 29.2M
  • IPO Year
  • NDLS 2013
  • GBIO 2020
  • Fundamental
  • Price
  • NDLS $0.89
  • GBIO $0.44
  • Analyst Decision
  • NDLS Strong Buy
  • GBIO Strong Buy
  • Analyst Count
  • NDLS 2
  • GBIO 4
  • Target Price
  • NDLS $3.00
  • GBIO $7.33
  • AVG Volume (30 Days)
  • NDLS 224.0K
  • GBIO 1.2M
  • Earning Date
  • NDLS 08-06-2025
  • GBIO 08-06-2025
  • Dividend Yield
  • NDLS N/A
  • GBIO N/A
  • EPS Growth
  • NDLS N/A
  • GBIO N/A
  • EPS
  • NDLS N/A
  • GBIO N/A
  • Revenue
  • NDLS $495,670,000.00
  • GBIO $24,556,000.00
  • Revenue This Year
  • NDLS $5.37
  • GBIO N/A
  • Revenue Next Year
  • NDLS $0.68
  • GBIO N/A
  • P/E Ratio
  • NDLS N/A
  • GBIO N/A
  • Revenue Growth
  • NDLS N/A
  • GBIO 146.47
  • 52 Week Low
  • NDLS $0.55
  • GBIO $0.30
  • 52 Week High
  • NDLS $1.83
  • GBIO $3.65
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 63.57
  • GBIO 63.54
  • Support Level
  • NDLS $0.66
  • GBIO $0.32
  • Resistance Level
  • NDLS $0.82
  • GBIO $0.36
  • Average True Range (ATR)
  • NDLS 0.09
  • GBIO 0.03
  • MACD
  • NDLS 0.03
  • GBIO 0.01
  • Stochastic Oscillator
  • NDLS 99.97
  • GBIO 93.40

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: